Litigation
Arbutus Pharma Corp. (f/k/a Arbutus Biopharma Corp.) et al. v. Pfizer Inc. et al.
pending2:23-cv-01876-ZNQ; 3:23-cv-01876
Auto-generating section 1 of 4: Case overview & background…
Each section takes ~30-60s with web-search grounding. Keep this tab open — sections will fill in below as they complete.
- Filed
- 2023-04-04
Patents at issue (5)
Defendants (2)
Summary
Arbutus and Genevant asserted five LNP patents, including the '359 patent, against Pfizer and BioNTech over Comirnaty. The action remains pending after a September 2025 claim construction ruling and was carved out of the Moderna settlement.
Case overview & background
Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Key legal developments & outcome
Major rulings, motions, claim construction, settlements, and the present posture or final disposition.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Plaintiff representatives
Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Defendant representatives
Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).